In poliovirus-infected HeLa-S3 cells, the protease inhibitors tolylsulfonylphenylalanyl chloromethyl ketone and iodoacetamide cause an accumulation of large precursor proteins, and they block viral RNA synthesis most probably via these products. Viral RNA polymerase activity can, however, be extracted by detergent containing buffer (Tris/Nonidet P-40, deoxycholate) from the inhibited cells. Only cytoplasmic extracts from infected cells treated with tolylsulfonyl-phenylalanyl chloromethyl ketone or iodoacetamide contain a protein which inhibits the in vitro polymerase reaction.
According to the present theories on viral RNA synthesis in poliovirus-infected cells, kinetics of RNA synthesis are determined by the mutual enhancing effect of protein synthesis and RNA synthesis since both processes are dependent upon each other. Only recently Cooper et al. (2) suggested that viral RNA synthesis is controlled by a principle of limiting regulation. Our observations support an additional means of regulation for viral RNA synthesis by a product occurring in infected cells. The short half-life of intracellular viral RNA polymerase activity is likely to be caused by cleavage of the enzyme molecules. Indeed, there is a rapid decrease of polymerase activity when protein synthesis is blocked by cycloheximide (4) .
In the present study inhibitors of the known post-translational cleavage of poliovirus proteins such as TLCK (tolylsulfonyl-lysylchloromethyl ketone), TPCK (tolylsulfonylphenylalanyl chloromethyl ketone), and IAA (iodoacetamide) (5, 6, 10) were used to "conserve" the viral RNA polymerase within the cell by preventing its cleavage. We found that under the influence of the inhibitors TPCK or IAA intracellular viral RNA synthesis stops. In these inhibited poliovirus-infected cells, however, the viral RNA polymerase was still present and could be extracted in an active form. We therefore investigated the mechanism of the observed inhibition of viral RNA synthesis.
This work is part of A. Ro5der's doctoral thesis presented to the University of Wulrzburg.
MATERIALS AND METHODS Cells. HeLa S3 cells (Flow Laboratories, Irvine, Scotland) were grown in suspension for 24 h before the experiments (7).
Virus. HeLa S3 monolayers were infected with poliovirus type 1 (Mahoney) (7) . After purification the titer was determined as described by Dulbecco (3) .
Preparation of the viral RNA polymerase complex. We used detergent extraction of the viral RNA polymerase activity as described by Ehrenfeld et al. (4) : 5 x 107 HeLa cells in 10 ml of Spinner medium without serum were infected with 50 to 100 PFU per cell. Forty-five minutes postinfection 40 ml of Spinner medium containing 5% calf serum was added. Cells were harvested at the times indicated, washed with phosphate-buffered saline (PBS), freeze-thawed in a dry ice-methanol (-78 C) bath three times, and centrifuged for 2 min at 750 x g. The supernatant is called 750 x g supernatant. The pellet was incubated at 37 C for 3 min with a mixture of anionic and nonionic detergent (Nonidet P-40/deoxycholate). After centrifugation at 20,000 x g for 30 min, the enzyme activity remains in the supernatant. This enzyme activity sediments with about 70S in a 7 to 47% (wt/vol) sucrose-gradient in Tris buffer A (10 mM Tris-hydrochloride, pH 8; 10 mM NaCl) in the ultracentrifuge (Beckman Spinco L 50, SW 25.1, 21,000 rpm, 17 h, 4 C). The enzyme activity from infected cells treated with protease inhibitors was prepared in the same manner.
Precipitation of enzyme activity with LiCl. By a technique analogous to the precipitation of the RI-RNA structure as described by Baltimore and Girard (1), the enzymatically active replication complex can be precipitated quantitatively by a final concentration of 2 M LiCl from the 20,000 x g supernatant or from the respective gradient fractions. After addition of an equal volume of 4 Amersham-Buchler, Braunschweig) were added to the cell suspension. At the times indicated, 5-ml portions (5 x 106 cells) were removed, washed three times in 10 ml of ice-cold PBS, precipitated with 3 ml of 5% trichloroacetic acid, collected on membrane filters, washed, dried, and counted as described above. The times of addition and the concentrations of the protease inhibitors TPCK, TLCK, and IAA are given in the figures and legends of the respective experiments.
RNase inhibitors. During the in vitro incorporation of [3HJUTP by viral RNA polymerase preparations in the presence of 750 x g supernatants, the following RNase inhibitors were added to the enzyme test: Polyvinylsulfate (Serva, Heidelberg), or the RNase inhibitor from rat liver as described by Roth (9) (Searle, High Wycome, Great Britain). Concentrations of the inhibitor are given in the legends to the figures. RESULTS Enzymatic properties of the LiCl-precipitated replication complex. The viral RNA replication complex was found to be precipitated fairly quantitatively by 2 M LiCl. This is shown in Fig. 1 . In this case the precipitate was dissolved in the original volume of buffer. Comparing precipitated and original preparations in the in vitro assay system no differences were found. The total amount of incorporated
[3H]UTP as well as the kinetics and duration of incorporation were virtually identical. Also, the supernatant of the LiCl-precipitation procedure showed almost no enzymatic activity. The
[3H]UTP incorporation measured in this reaction was RNase sensitive. Preparations from uninfected cells contained no enzymatic activity. The product of the in vitro reaction with the LiCl-precipitated complex consisted almost exclusively of the RNase-resistant 18S-ds-RNA (Fig. 2) . Thus, with respect to these properties the LiCl-precipitated complex and the detergent-extracted complex described by Ehrenfeld et al. (4) were indistinguishable.
Influence of protease inhibitors on viral RNA synthesis in vivo and in vitro. Viral RNA synthesis was studied in vivo in the presence of 5 x 10-4 M TPCK and IAA, respectively. The addition of either TPCK or IAA 1 h postinfection, that is, at the beginning of the infectious cycle, prevented RNA multiplication completely (Fig. 3B and C) . If RNA multiplication had already reached its maximal rate at the time the protease inhibitor was added, the further synthesis was totally blocked within 15 to 20 min ( Fig. 3B and C) . TLCK caused only a slight reduction of total RNA synthesis (Fig. 3A) , .
TPCK or IAA (each 5 x 10-i M) or without drugs. The data (Fig. 4) thus strongly suggests that viral RNA synthesis itself was arrested by TPCK or IAA. These results indicated that those protease inhibitors which lead to an accumulation of large precursor proteins also had a very strong inhibitory effect on the prevailing RNA synthesis in the cell. Lowering the concentrations of the drugs lead to a successively lower inhibition of viral RNA synthesis. At a concentration 10-6 M the remaining effect was barely significant. The protease inhibitors used had no direct influence on the in vitro reaction of the detergent-solubilized RNA polymerase (Fig. 5) . The following experiments thus became feasible.
Isolation of the replication complex from inhibitor-treated in vivo systems. Here it was studied whether active viral polymerase can be isolated from inhibitor-treated samples. This is not the case when protein synthesis is inhibited by cycloheximide (4) (Fig. 6A) . Surprisingly, however, even after a 1-h treatment with either TPCK or IAA, enzymatically active complexes were extractable (Fig. 6B and C) . The activity could still be isolated even if the protease inhibitor was present throughout the purification procedure. This procedure served as control to further eliminate the possibility that proteolytic cleavage occurs during the purification steps, which include a short incubation at 37 C (see Materials and Methods). The extractable enzymatic activity was almost completely retained even though viral RNA synthesis in the (Fig. 7A) (Fig. 7B) supernatants from uninfected cells, both inhibitor-treated and untreated. On the other hand, the inhibition produced by the supernatants from TPCK-or IAA-treated infected cells could not be reversed (Fig. 7C) .
To examine the nature of the inhibitory material, 750 x g supernatants from TPCKinhibited cells were treated with proteases. TPCK is a specific inhibitor for chymotrypsin, therefore, the treatment with cellulose-bound trypsin (Merck, Darmstadt) was chosen. After an incubation period of 60 min at 37 C, the remaining inhibitory capacity was tested in vitro (Fig. 8) . The trypsin-treated fraction had lost its inhibitory capacity. In contrast, a portion of this supernatant incubated under identical conditions but without trypsin was still inhibitory and to the same extent as an untreated control. DISCUSSION The analysis of viral proteins shows that treatment with TPCK or IAA leads to a preferential accumulation of viral proteins with a molecular weight higher than that of NCVP1. Under normal conditions these proteins are rapidly cleaved into smaller fragments. It is of FIG. 8. Influence of a 750 x g supernatant from TPCK-treated infected cells on viral polymerase reaction in vitro after treatment with cellulose-bound trypsin (Merck, Darmstadt). From 2 x 108 infected cells treated with TPCK the 750 x g supernatant was prepared and divided in three parts. The first one remained untreated, the second was incubated 60 min at 37 C, the third incubated 60 min at 37 C with cellulose-bound trypsin (5 mg of cellulose-bound trypsin per mg of protein in the supernatant; after incubation trypsin was put away by pelleting at 750 x g for 2 min). These fractions are tested in the in vitro system; the conditions for this assay are given in Fig.   7 . All mixtures contained 100 jig of PVS as RNaseinhibitor. I, Without 750 x g superantant; II, with untreated supernatant; III, with supernatant, incubated with trypsin; IV, with supernatant, incubated without trypsin.
interest that the protease inhibitor TLCK did not strongly inhibit the cleavage in our cells. Likewise, the viral RNA synthesis was not blocked in this case. The proteins which accumulate under TPCK and IAA seem to be identical with the natural intermediary products described by Korant (5) . He Thus, one may assume that one or several of these intermediary proteins are responsible for the inhibition of viral RNA synthesis observed in vivo and in vitro. In a following paper we will describe the results of protein analyses which will support this notion. Although this protein under normal conditions is rapidly cleaved, it may exert a control on viral RNA synthesis. This would lead to a limited synthesis but not to a fully blocked polymerase activity. Only under the experimental inhibition of cleavage by TPCK or IAA would the product accumulate sufficiently to cause a total inhibition of the viral RNA synthesis in the cell. Indeed, only under these conditions is it possible to demonstrate the existence of an inhibitory protein using the in vitro assay system. The isolation and purification of the inhibitory protein(s) are in progress.
